Optimal Electrolyte Orange

Optimal Electrolyte Orange

Seeking Health4.8 (101 ratings)
Format:Powder Quantity: 30 Stick Pack(s) · 30 servings
Goals
$40.00 $1.33 per serving

Product analysis

66 out of 100

Optimal Electrolyte Orange provides potassium with a limited role in supporting normal blood-pressure regulation. Its added taurine and creatine offer weak value for the cost.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality61

Potassium has a favorable, clearly named form, and the niacin type is disclosed. Quality remains uncertain for the other ingredients, including the named creatine blend.

Ingredient Transparency83

Ingredient amounts are disclosed, making serving quantities easy to compare. Some forms are unnamed, leaving the label less specific about what it supplies.

Value For Money51

The product is more reasonably priced for its sodium and potassium than for its added ingredients. Taurine, niacin and creatine provide weak value when the full serving cost is considered.

Customer Satisfaction73

Customer ratings are strongly positive. The modest review base offers some reassurance about satisfaction, though it remains limited.

Product Focus66

The main heart-health connection comes from potassium, whose effects depend on usual intake and starting blood pressure. Taurine is present well below the amount used in the relevant research.

Format
Powder
Container
30 Stick Pack(s)
Per serving
$1.33
Customer rating
4.8 · 101 ratings
Report analysis

Goals

Heart Health
Impact
High effect
C- Ingredient FitD- PathwaysA EvidenceA+ Formulation Logic
Taurine · 250 mg
Study evidence
Niacin Supportive 105 studies
Potassium Supportive 182 studies
Taurine Supportive 25 studies

Ingredients

IngredientAmount per servingScore
Calories
15 Calorie(s)
Total Carbohydrates
4 Gram(s)
Niacin (Inositol Hexanicotinate)
25 mg 54
Creatine MagnaPower (Magnesium)
150 mg
Sodium (Sodium Bicarbonate)
140 mg 58
Potassium (Potassium Bicarbonate)
510 mg 91
D-Ribose
2 Gram(s)
Taurine
250 mg 53
Creatine (Creatine MagnaPower Magnesium Creatine Chelate)
225 mg 46
Gluten Free Adults 18–50 Dairy Free
Report overview
A+ Active Ingredient Quality & BioavailabilityA- Dose, Safety & Label TransparencyB+ Value
Each serving provides 510 mg of potassium at a moderate cost per serving. It uses Potassium Bicarbonate.
How this ingredient is rated

Active Ingredient Quality & Bioavailability100

It uses Potassium Bicarbonate.
Potassium Form Quality
It uses Potassium Bicarbonate.

Dose, Safety & Label Transparency88

Each serving provides 510 mg of potassium. The potassium amount is stated, though it is not explicitly labeled elemental potassium.
Potassium Dosage Potency
Each serving provides 510 mg of potassium.
Elemental Yield Transparency
The potassium amount is stated, though it is not explicitly labeled elemental potassium.

Value80

The cost per serving is moderate.
Potassium Value Efficiency
The cost per serving is moderate.
B- Active Ingredient Quality & BioavailabilityF Dose, Safety & Label TransparencyB+ Value
Each serving provides 140 mg sodium at a moderate whole-product cost. The listed sodium forms include Sodium Bicarbonate. The serving also contains 510 mg potassium.
How this ingredient is rated

Active Ingredient Quality & Bioavailability70

The listed sodium forms include Sodium Bicarbonate. The serving also contains 510 mg potassium.
Sodium Source Purity & Quality
The listed sodium forms include Sodium Bicarbonate.
Bioavailability of Supporting Electrolytes
The serving also contains 510 mg potassium.
Trace Mineral Complex & Buffering Forms
Sodium bicarbonate is listed and can help buffer lactic acid.

Dose, Safety & Label Transparency35

Sodium and potassium amounts are stated; the magnesium amount for the selected serving is unclear. No artificial colors or sweeteners are identified in the available ingredient information.
Sodium Dosage for Athletic Replenishment
Each serving contains 140 mg sodium. That is a modest contribution for replacing sweat loss during intense activity.
Ingredient Label Transparency
Sodium and potassium amounts are stated; the magnesium amount for the selected serving is unclear.
Artificial Color and Sweetener Disclosure
No artificial colors or sweeteners are identified in the available ingredient information.

Value80

The whole-product cost per serving is moderate.
Price Per Serving vs. Collection Median
The whole-product cost per serving is moderate.
C- Active Ingredient Quality & BioavailabilityC+ Dose, Safety & Label TransparencyF Value
Each serving provides 25 mg of niacin. The serving price is high when attributed to this ingredient alone; that may overstate its cost. It uses inositol hexanicotinate.
How this ingredient is rated

Active Ingredient Quality & Bioavailability57

It uses inositol hexanicotinate.
Niacin Form & Goal Alignment
Inositol Hexanicotinate is the stated form.
Precursor Source Quality
The stated source is inositol hexanicotinate.

Dose, Safety & Label Transparency67

Each serving provides 25 mg of niacin. No no-flush claim is recorded.
Clarity of Chemical Form
The form is disclosed as Inositol Hexanicotinate.
Form-Specific Dosage Efficacy
Each serving provides 25 mg of niacin.
Flush Risk & Safety Labeling
No no-flush claim is recorded.

Value20

The serving price is high when attributed to this ingredient alone; that may overstate its cost.
Price Per Effective Serving
The serving price is high when attributed to this ingredient alone; that may overstate its cost.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Differential effect of two nicotinic acid preparations on low-density lipoprotein subclass distribution in patients classified as low-density lipoprotein pattern A, B, or I.
    Superko HR; McGovern ME; Raul E; Garrett B · The American journal of cardiology · 2004
    Randomized trial180 participantsHeart Health forNiacin
  2. The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis): final results and the impact of medication adherence, dose, and treatment duration.
    Villines TC; Stanek EJ; Devine PJ; Turco M; Miller M; Weissman NJ; Griffen L; Taylor AJ · Journal of the American College of Cardiology · 2010
    Randomized trial315 participantsHeart Health forNiacin
  3. The effects of extended-release niacin on carotid intimal media thickness, endothelial function and inflammatory markers in patients with the metabolic syndrome.
    Thoenes M; Oguchi A; Nagamia S; Vaccari CS; Hammoud R; Umpierrez GE; Khan BV · International journal of clinical practice · 2008
    Randomized trial50 participantsHeart Health forNiacin
  4. Effect of niacin therapy on cardiovascular outcomes in patients with coronary artery disease.
    Duggal JK; Singh M; Attri N; Singh PP; Ahmed N; Pahwa S; Molnar J; Singh S; Khosla S; Arora R · Journal of cardiovascular pharmacology and therapeutics · 2010
    Meta-analysis5,137 participants7 studies pooledHeart Health forNiacin
  5. Effect of niacin on endothelial function: a systematic review and meta-analysis of randomized controlled trials.
    Sahebkar A · Vascular medicine (London, England) · 2014
    Meta-analysis441 participants7 studies pooledHeart Health forNiacin
  6. Potassium intake, stroke, and cardiovascular disease a meta-analysis of prospective studies.
    D'Elia L; Barba G; Cappuccio FP; Strazzullo P · Journal of the American College of Cardiology · 2011
    Meta-analysis247,510 participants11 studies pooledHeart Health forPotassium
  7. Oral potassium supplementation for management of essential hypertension: A meta-analysis of randomized controlled trials.
    Poorolajal J; Zeraati F; Soltanian AR; Sheikh V; Hooshmand E; Maleki A · PloS one · 2017
    Meta-analysis1,213 participants23 studies pooledHeart Health forPotassium
  8. Joint association of urinary sodium and potassium excretion with cardiovascular events and mortality: prospective cohort study.
    O'Donnell M; Mente A; Rangarajan S; McQueen MJ; O'Leary N; Yin L; Liu X; Swaminathan S; Khatib R; Rosengren A; Ferguson J; Smyth A; Lopez-Jaramillo P; Diaz R; Avezum A; Lanas F; Ismail N; Yusoff K; Dans A; Iqbal R; Szuba A; Mohammadifard N; Oguz A; Yusufali AH; Alhabib KF; Kruger IM; Yusuf R; Chifamba J; Yeates K; Dagenais G; Wielgosz A; Lear SA; Teo K; Yusuf S; PURE Investigators · BMJ (Clinical research ed.) · 2019
    Cohort study103,570 participantsHeart Health forPotassium
  9. Effect of Potassium Supplementation on Endothelial Function: A Systematic Review and Meta-Analysis of Intervention Studies.
    D'Elia L; Cappuccio FP; Masulli M; La Fata E; Rendina D; Galletti F · Nutrients · 2023
    Meta-analysis332 participants5 studies pooledHeart Health forPotassium
  10. Effects of potassium supplementation on office, home, and 24-h blood pressure in patients with essential hypertension.
    Kawano Y; Minami J; Takishita S; Omae T · American journal of hypertension · 1999
    Randomized trial55 participantsHeart Health forPotassium
  11. Taurine ameliorates blood pressure and vascular function in patients with type 2 diabetes: Randomized, double-blind, placebo-controlled trial.
    Li Y; Wang Q; Liu Y; Li Q; Xia W; Lin S; Yang Q; Scholze A; Zhao Z; He H; Zhang H; Yan Z; Tepel M; Mu H; Zhu Z; Liu D · iScience · 2025
    Randomized trial165 participantsHeart Health forTaurine
  12. Seafood diets: hypolipidemic and antiatherogenic effects of taurine and n-3 fatty acids.
    Elvevoll EO; Eilertsen KE; Brox J; Dragnes BT; Falkenberg P; Olsen JO; Kirkhus B; Lamglait A; Østerud B · Atherosclerosis · 2009
    Randomized trial80 participantsHeart Health forTaurine
  13. Taurine Supplementation Lowers Blood Pressure and Improves Vascular Function in Prehypertension: Randomized, Double-Blind, Placebo-Controlled Study.
    Sun Q; Wang B; Li Y; Sun F; Li P; Xia W; Zhou X; Li Q; Wang X; Chen J; Zeng X; Zhao Z; He H; Liu D; Zhu Z · Hypertension (Dallas, Tex. : 1979) · 2016
    Randomized trial120 participantsHeart Health forTaurine
  14. The effects of taurine supplementation on obesity, blood pressure and lipid profile: A meta-analysis of randomized controlled trials.
    Guan L; Miao P · European journal of pharmacology · 2021
    Meta-analysis12 studies pooledHeart Health forTaurine
  15. The Effects of Oral Taurine on Resting Blood Pressure in Humans: a Meta-Analysis.
    Waldron M; Patterson SD; Tallent J; Jeffries O · Current hypertension reports · 2019
    Meta-analysis103 participants7 studies pooledHeart Health forTaurine